GKOS241220C85000
- 0.00
- 0.000.00%
Glaukos Newsroom
Insider Sale: Director at $GKOS (GKOS) Sells 2,000 Shares
J.P. Morgan Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $160
Glaukos (GKOS) Receives a Buy From J.P. Morgan
Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $153
Here's Why You Should Add Glaukos Stock to Your Portfolio Now
Glaukos Raised to Buy From Neutral by Citigroup
Glaukos Price Target Raised to $162.00/Share From $132.00 by Citigroup
Wells Fargo Maintains Glaukos(GKOS.US) With Buy Rating, Raises Target Price to $153
Express News | Glaukos Corp. : Wells Fargo Raises Target Price to $153 From $145
Citi Upgrades Glaukos(GKOS.US) to Buy Rating, Raises Target Price to $162
BTIG Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $149
This Constellation Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
UBS Initiates Glaukos(GKOS.US) With Buy Rating, Announces Target Price $182
Strong Growth Potential Drives Buy Rating for Glaukos Amidst Market Disruption by IDose
How Is The Market Feeling About Glaukos?
Express News | Glaukos Corp - Entered Into Unwind Agreements With Certain Financial Institutions for Capped Call Transactions
Morgan Stanley Bullish on Medtech in 2025, Upgrades 5 Stocks
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Glaukos Is Maintained at Buy by Stifel
This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday